Literature DB >> 11196201

Proteomic analysis reveals that 14-3-3sigma is down-regulated in human breast cancer cells.

A S Vercoutter-Edouart1, J Lemoine, X Le Bourhis, H Louis, B Boilly, V Nurcombe, F Révillion, J P Peyrat, H Hondermarck.   

Abstract

The class of molecular chaperones known as 14-3-3 is involved in the control of cellular growth by virtue of its apparent regulation of various signaling pathways, including the Raf/mitogen-activated protein kinase pathway. In breast cancer cells, the sigma form of 14-3-3 has been shown to interact with cyclin-dependent kinases and to control the rate of entry into mitosis. To test for a direct role for 14-3-3 in breast epithelial cell neoplasia, we have quantitated 14-3-3 protein levels using a proteomic approach based on two-dimensional electrophoresis and matrix-assisted laser desorption/ionization mass spectrometry (MALDI-TOF). We show here that 14-3-3sigma protein is strongly down-regulated in the prototypic breast cancer cell lines MCF-7 and MDA-MB-231 and in primary breast carcinomas as compared with normal breast epithelial cells. In contrast, levels of the alpha, beta, delta, or zeta isoforms of 14-3-3 were the same in both normal and transformed cells. The data support the idea that 14-3-3sigma is involved in the neoplastic transition of breast epithelial cells by virtue of its role as a tumor suppressor; as such, it may constitute a robust marker with clinical efficacy for this pathology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11196201

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  37 in total

1.  Identification of differentially expressed proteins between human esophageal immortalized and carcinomatous cell lines by two-dimensional electrophoresis and MALDI-TOF-mass spectrometry.

Authors:  Xing-Dong Xiong; Li-Yan Xu; Zhong-Ying Shen; Wei-Jia Cai; Jian-Min Luo; Ya-Li Han; En-Min Li
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

Review 2.  Current perspectives in cancer proteomics.

Authors:  Miriam V Dwek; Sarah L Rawlings
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

Review 3.  Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes.

Authors:  Carol Mackintosh
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

4.  A novel role for 14-3-3sigma in regulating epithelial cell polarity.

Authors:  Chen Ling; Dongmei Zuo; Bin Xue; Senthil Muthuswamy; William J Muller
Journal:  Genes Dev       Date:  2010-05       Impact factor: 11.361

5.  Determinants of 14-3-3σ protein dimerization and function in drug and radiation resistance.

Authors:  Zhaomin Li; Hui Peng; Li Qin; Jing Qi; Xiaobing Zuo; Jing-Yuan Liu; Jian-Ting Zhang
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

6.  Breast cancer and protein biomarkers.

Authors:  Lay-Harn Gam
Journal:  World J Exp Med       Date:  2012-10-20

7.  Silencing Filamin A Inhibits the Invasion and Migration of Breast Cancer Cells by Up-regulating 14-3-3σ.

Authors:  Zhi-Min Ji; Li-Li Yang; Juan Ni; San-Peng Xu; Cheng Yang; Pei Duan; Li-Ping Lou; Qiu-Rong Ruan
Journal:  Curr Med Sci       Date:  2018-06-22

8.  14-3-3sigma, the double-edged sword of human cancers.

Authors:  Zhaomin Li; Jing-Yuan Liu; Jian-Ting Zhang
Journal:  Am J Transl Res       Date:  2009-06-08       Impact factor: 4.060

9.  Overexpression of 14-3-3σ counteracts tumorigenicity by positively regulating p73 in vivo.

Authors:  Cuizhi Geng; Meixiang Sang; Ruiling Yang; Wei Gao; Tao Zhou; Shijie Wang
Journal:  Oncol Lett       Date:  2011-08-31       Impact factor: 2.967

10.  Presence and distribution of 14-3-3 proteins in human ocular surface tissues.

Authors:  Jwalitha Shankardas; Michelle Senchyna; Slobodan D Dimitrijevich
Journal:  Mol Vis       Date:  2008-12-31       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.